Skip to main content

VitVio

Category: AI in Healthcare

A computer vision and AI platform designed to digitize the operating room by automating administrative tasks and surgical workflow documentation through ambient sensing. VitVio was founded in 2022. The company is led by Thomas Knox. Based in Boston, USA. Team size: 10-50. Total funding raised: $10M ($8M Seed + $2M earlier). Latest round: Seed ($8M, Oct 2025). Key investors include ["Bek Ventures","LDV Capital","Tiny Supercomputer Investment Company (TSIC)","Balnord","Thornapple River Capital","Mati Staniszewski"].

Founded
2022
Headquarters
Boston, USA
Team size
10-50
Total funding
$10M ($8M Seed + $2M earlier)

Value proposition

Reduces the administrative burden on surgical teams by automating manual data entry, improving OR throughput, and providing real-time operational insights to maximize hospital ROI.

Products and solutions

["Ambient Sensing OR Platform","Automated Surgical Log & Documentation Engine","Real-time OR Workflow Analytics Dashboard","Instrument and Asset Tracking System","Surgical Team Coordination Tools"]

Unique value

Applies 'autonomous retail' grade computer vision technology to the surgical theater, allowing for 'zero-click' data capture without requiring staff to wear sensors or interact with screens.

Target customer

Health systems, large hospitals, ambulatory surgery centers (ASCs), and surgical department administrators.

Industries served

["Healthcare","HealthTech","Surgical Operations","Hospital Administration"]

Technology advantage

Leverages proprietary computer vision models developed by pioneers in autonomous checkout (AiFi/Standard AI) to track complex human-object interactions in high-stakes clinical environments with high precision.

How they differentiate

VitVio utilizes 'zero-click' ambient sensing technology derived from autonomous retail (computer vision) to automate administrative and operational logistics. Unlike competitors that focus primarily on surgical technique or video-based clinical coaching, VitVio focuses on the 'OR as a factory,' automating documentation and asset tracking without requiring staff interaction with screens.

Main competitors

["Theator","Caresyntax","ExplORer Surgical (GHX)"]

Key partnerships

["Royal Orthopaedic Hospital (Clinical validation partner)","Bek Ventures","LDV Capital","Tiny Supercomputer Investment Company (TSIC)"]

Notable customers

["Royal Orthopaedic Hospital"]

Major milestones

["Relocated global headquarters to Boston, MA in 2024","Successfully completed clinical validation pilot with the Royal Orthopaedic Hospital","Closed $8M Seed funding round led by Bek Ventures in January 2025"]

Growth metrics

Expanding operations from the UK to a new headquarters in Boston; currently scaling from clinical validation to commercial deployment across US health systems.

Market positioning

Early-stage disruptor in the Surgical Operations and HealthTech infrastructure market.

Geographic focus

North America and United Kingdom

Patents and IP

Proprietary IP in computer vision algorithms and ambient sensing configurations for clinical environments (specific public filings not disclosed).

About Thomas Knox

Thomas Knox is a seasoned product leader with a specialized background in scaling computer vision and AI startups. Prior to founding VitVio, he held key leadership roles at autonomous retail pioneers AiFi and Standard AI, where he oversaw the deployment of AI solutions across 150+ locations. His experience also includes scaling the travel platform Kiwi.com and serving as a member of the Forbes Technology Council.

Official website: